Menu

Blog

Page 3015

Dec 27, 2022

Immune checkpoint inhibitors: Immunotherapy for people with triple-negative breast cancer

Posted by in categories: biotech/medical, health

Immunotherapy is a type of drug that might be an option if you have triple-negative breast cancer.

Triple-negative breast cancer, also called basal-like breast cancer, is not sensitive to hormones. This means that the breast cancer cells don’t use estrogen or progesterone to grow and they don’t have hormone receptors. This type of breast cancer also doesn’t produce too much of the growth-promoting protein called HER2.

“Triple-negative breast cancer is about 10% to 15% of all breast cancer cases,” says Pooja Advani, M.D., a medical oncologist with the Robert and Monica Jacoby Center for Breast Health at Mayo Clinic in Florida.

Dec 27, 2022

USDA approves GMO purple tomato with brain-boosting and cancer-fighting properties

Posted by in categories: bioengineering, biotech/medical, food, genetics, neuroscience

Although genetically modified foods still get a bit of a bad rap, there are actually many good reasons why modifying an organism’s genetics may be worthwhile. For example, many breeds of genetically modified foods have made them more resistant to disease.

It’s also possible to modify foods to make them more nutritious. Take, for example, golden rice. This grain was engineered to have higher levels of vitamin A in order to tackle deficiencies of this nutrient in impoverished countries.


A purple tomato, created using genetic modification, may be available to buy in the U.S. as soon as 2023.

Dec 27, 2022

The Future of Data Science and AI: Careers in Data Science

Posted by in categories: robotics/AI, science

Join the Pan Asian Alumni Network (PAAN) and the Alumni Club of New York City for a series of virtual panels featuring diverse perspectives from the UChicago alumni community exploring career pathways, philosophical questions and trends determining the future of data science and artificial intelligence.

The first program in our series, Careers in Data Science, brings together UChicago alumni across different industries to discuss their career pathways, highlight key industry trends, and share advice for anyone looking to break into these fields.

Dec 27, 2022

Gravitas: South Korea reports first ‘brain-eating amoeba’ death

Posted by in category: neuroscience

South Korea has reported its first death due to Naegleria fowleri or ‘Brain-eating amoeba.’ The amoeba enters through the nose and attacks the brain, causing meningitis. Should you be scared?

#SouthKorea #amoeba #WION

Continue reading “Gravitas: South Korea reports first ‘brain-eating amoeba’ death” »

Dec 27, 2022

New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in Blood

Posted by in categories: biotech/medical, neuroscience

PITTSBURGH — A group of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a test to detect a novel marker of Alzheimer’s disease neurodegeneration in a blood sample. A study on their results was published today in Brain.

The biomarker, called “brain-derived tau,” or BD-tau, outperforms current blood diagnostic tests used to detect Alzheimer’s-related neurodegeneration clinically. It is specific to Alzheimer’s disease and correlates well with Alzheimer’s neurodegeneration biomarkers in the cerebrospinal fluid (CSF).


A group of neuroscientists led by a Pitt School of Medicine researcher developed a test to detect a novel marker of Alzheimer’s disease neurodegeneration in a blood sample.

Dec 27, 2022

New Materials Will Bring the Next Generation of Quantum Computers

Posted by in categories: computing, quantum physics

This technology is primed to become faster, more versatile, and—thankfully—cheaper.

Dec 27, 2022

Weather looking good for early SpaceX launch from Cape Canaveral

Posted by in categories: internet, satellites

Weather should be ideal for the early Wednesday launch of a SpaceX Falcon 9 rocket with Starlink internet satellites.

Dec 27, 2022

Missouri S&T professor is looking to AI to help with kidney transplants

Posted by in categories: biotech/medical, robotics/AI

A four-year study will help develop AI software that will speed up the process of matching donated kidneys with patients in need, especially those not at the top of the transplant list.

Dec 27, 2022

Giant laser from ‘Star Trek’ to be tested in fusion breakthrough

Posted by in categories: innovation, nuclear energy

The breakthrough came in an impossibly small slice of time, less than it takes a beam of light to move an inch. In that tiny moment, nuclear fusion as an energy source went from far-away dream to reality. The world is now grappling with the implications of the historic milestone. For Arthur Pak and the countless other scientists who’ve spent decades getting to this point, the work is just beginning.

Pak and his colleagues at Lawrence Livermore National Laboratory are now faced with a daunting task: Do it again, but better—and bigger.

That means perfecting the use of the world’s largest laser, housed in the lab’s National Ignition Facility that science-fiction fans will recognize from the film “Star Trek: Into Darkness,” when it was used as a set for the warp core of the starship Enterprise. Just after 1 a.m. on Dec. 5, the laser shot 192 beams in three carefully modulated pulses at a cylinder containing a tiny diamond capsule filled with hydrogen, in an attempt to spark the first fusion reaction that produced more than it took to create. It succeeded, starting the path toward what scientists hope will someday be a new, carbon-free power source that will allow humans to harness the same source of energy that lights the stars.

Dec 27, 2022

A Dune-inspired spacecraft could finally reveal what dark matter is made of

Posted by in category: cosmology

Instead, this nimble satellite will punch hugely above its weight and try to track down one of the most elusive and mysterious substances in the universe: dark matter. This is the term given to the hypothetical invisible matter that is thought to be more abundant than normal matter and has a similar gravitational effect on its surroundings.

The mission is classified as fast (F), which means it is smaller, more focused, and has a quicker turnaround (less than 10 years to launch) than other types of ESA missions. The agency’s previous F-mission, selected in 2019, is called the Comet Interceptor. Already parked at a stable point in the Solar System, this probe is waiting for a comet to show up and fly by it, something that’s due to happen around the time that Arrakhis launches in the early 2030s.

Since dark matter still eludes detection, the mission will target sources of light that are sensitive to it. We expect normal matter — the stuff that actually emits light, such as stars in galaxies — to move primarily under the influence of dark matter, which is more abundant.